Efficacy and Safety of Baricitinib or Ravulizumab in Adult Patients with Severe COVID-19 (TACTIC-R): a Randomised, Parallel-Arm, Open-Label, Phase 4 Trial.
The Lancet Respiratory medicine(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
The Lancet Respiratory medicine(2023)